(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 1.8B | +8% |
Gross Profit | 294.2MM | - |
Cost Of Revenue | 1.5B | +3% |
Operating Income | 194MM | +70% |
Operating Expenses | 100.2MM | - |
Net Income | 96.9MM | - |
G&A | 48.4MM | +10% |
Amortization | - | - |
Interest Expense | 50.8MM | -0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The board of Select Medical Holdings Corporation ( NYSE:SEM ) has announced that it will pay a dividend of $0.125 per...
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
A week ago, Select Medical Holdings Corporation ( NYSE:SEM ) came out with a strong set of first-quarter numbers that...
Select Medical Holdings Corporation (NYSE:SEM) Q1 2024 Earnings Call Transcript May 3, 2024 Select Medical Holdings Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and thank you for joining us today for Select Medical Holdings Corporation’s Earnings […]
Select Medical Holdings ( NYSE:SEM ) First Quarter 2024 Results Key Financial Results Revenue: US$1.79b (up 7.4% from...
SEM reports robust revenue and EBITDA growth, with significant strategic developments enhancing future prospects.
Q1 2024 Select Medical Holdings Corp Earnings Call
Robust Growth in Critical Illness and Rehabilitation Segments Drive Performance